Skip to main
HUM

Humana (HUM) Stock Forecast & Price Target

Humana (HUM) Analyst Ratings

Based on 20 analyst ratings
Hold
Strong Buy 10%
Buy 10%
Hold 70%
Sell 5%
Strong Sell 5%

Bulls say

Humana is in a favorable position in the healthcare industry, with a focus on government-sponsored programs and a growing membership base. The company's multi-year earnings recovery plan, including a target of at least 3% Medicare Advantage margin by 2028, is on track with key metrics such as utilization and risk scores tracking in line or better than guidance and indications of progress in 2027. Humana's proactive moves to optimize its balance sheet and divest non-core assets further supports its financial health.

Bears say

Humana is heavily reliant on government-sponsored healthcare programs, leaving them vulnerable to potential policy and regulatory changes. The company is also facing pressure from increasing competition in the Medicare Advantage market. Additionally, concerns about the impact of flu and weather on utilization trends, as well as ongoing cost initiatives, may limit potential earnings growth.

Humana (HUM) has been analyzed by 20 analysts, with a consensus rating of Hold. 10% of analysts recommend a Strong Buy, 10% recommend Buy, 70% suggest Holding, 5% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Humana (HUM) Forecast

Analysts have given Humana (HUM) a Hold based on their latest research and market trends.

According to 20 analysts, Humana (HUM) has a Hold consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $249.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $249.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Humana (HUM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.